Pulmonx (LUNG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.78, -3.78% vs the prior close of $1.85.
- Volume 243.99K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LUNG slides 3.8% to $1.78. Closed at $1.78, -3.78% vs the prior close of $1.85. Day range $1.75–$1.88, opened at $1.85.
LUNG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LUNG slides 3.8% to $1.78
- Closed at $1.78, -3.78% vs the prior close of $1.85. Day range $1.75–$1.88, opened at $1.85.
- Volume was 243.99K shares, 0.6x its 50-day average of 375.79K.
- Price is -14.0% vs its 50-day average ($2.07) and +7.6% vs its 200-day average ($1.65).
- 52-week range $1.13–$2.89; today's close sits at 37% of that range, 38.4% below the 52-week high.
Oct 15, 2026 — LUNG jumps 3.9% to $1.85
- Closed at $1.85, +3.93% vs the prior close of $1.78. Day range $1.77–$1.88, opened at $1.77.
- Volume was 268.10K shares, 0.7x its 50-day average of 381.60K.
- Price is -10.8% vs its 50-day average ($2.07) and +11.7% vs its 200-day average ($1.66).
- 52-week range $1.13–$2.89; today's close sits at 41% of that range, 36.0% below the 52-week high.
Oct 14, 2026 — LUNG rises 1.1% to $1.78
- Closed at $1.78, +1.14% vs the prior close of $1.76. Day range $1.72–$1.80, opened at $1.80.
- Volume was 284.90K shares, 0.7x its 50-day average of 397.11K.
- Price is -14.3% vs its 50-day average ($2.08) and +7.3% vs its 200-day average ($1.66).
- 52-week range $1.13–$2.89; today's close sits at 37% of that range, 38.4% below the 52-week high.
Oct 13, 2026 — LUNG dips 2.2% to $1.76, a 1-month low
- Closed at $1.76, -2.22% vs the prior close of $1.80. Day range $1.74–$1.87, opened at $1.79.
- Volume was 498.60K shares, 1.2x its 50-day average of 431.41K.
- Price is -15.5% vs its 50-day average ($2.08) and +6.0% vs its 200-day average ($1.66).
- 52-week range $1.13–$2.89; today's close sits at 36% of that range, 39.1% below the 52-week high.
Oct 12, 2026 — LUNG dips 2.2% to $1.80
- Closed at $1.80, -2.17% vs the prior close of $1.84. Day range $1.74–$1.93, opened at $1.81.
- Volume was 428.70K shares, 0.9x its 50-day average of 456.47K.
- Price is -13.9% vs its 50-day average ($2.09) and +8.2% vs its 200-day average ($1.66).
- 52-week range $1.13–$2.89; today's close sits at 38% of that range, 37.7% below the 52-week high.
Oct 9, 2026 — LUNG rises 1.7% to $1.84
- Closed at $1.84, +1.66% vs the prior close of $1.81. Day range $1.81–$1.90, opened at $1.81.
- Volume was 204.40K shares, 0.4x its 50-day average of 548.48K — lighter than usual.
- Price is -11.8% vs its 50-day average ($2.09) and +10.5% vs its 200-day average ($1.67).
- 52-week range $1.13–$2.89; today's close sits at 40% of that range, 36.3% below the 52-week high.
Oct 8, 2026 — LUNG dips 1.6% to $1.81
- Closed at $1.81, -1.63% vs the prior close of $1.84. Day range $1.77–$1.84, opened at $1.84.
- Volume was 229.20K shares, 0.4x its 50-day average of 548.52K — lighter than usual.
- Price is -13.1% vs its 50-day average ($2.08) and +8.5% vs its 200-day average ($1.67).
- 52-week range $1.13–$2.89; today's close sits at 39% of that range, 37.4% below the 52-week high.
Oct 7, 2026 — LUNG jumps 3.4% to $1.84
- Closed at $1.84, +3.37% vs the prior close of $1.78. Day range $1.75–$1.90, opened at $1.75.
- Volume was 379.70K shares, 0.7x its 50-day average of 545.85K.
- Price is -11.2% vs its 50-day average ($2.07) and +10.0% vs its 200-day average ($1.67).
- 52-week range $1.13–$2.89; today's close sits at 40% of that range, 36.3% below the 52-week high.
Oct 6, 2026 — LUNG slides 5.3% to $1.78, a 1-month low
- Closed at $1.78, -5.32% vs the prior close of $1.88. Day range $1.77–$1.93, opened at $1.90.
- Volume was 201.30K shares, 0.4x its 50-day average of 546.77K — lighter than usual.
- Price is -13.6% vs its 50-day average ($2.06) and +6.2% vs its 200-day average ($1.68).
- 52-week range $1.13–$2.89; today's close sits at 37% of that range, 38.4% below the 52-week high.
Oct 5, 2026 — LUNG rises 2.7% to $1.88
- Closed at $1.88, +2.73% vs the prior close of $1.83. Day range $1.79–$1.92, opened at $1.85.
- Volume was 283.70K shares, 0.5x its 50-day average of 545.87K — lighter than usual.
- Price is -8.2% vs its 50-day average ($2.05) and +12.0% vs its 200-day average ($1.68).
- 52-week range $1.13–$2.89; today's close sits at 43% of that range, 34.9% below the 52-week high.
Oct 2, 2026 — LUNG slides 4.2% to $1.83, a 1-month low, 3 down days in a row
- Closed at $1.83, -4.19% vs the prior close of $1.91. Day range $1.83–$1.93, opened at $1.92.
- Volume was 175.00K shares, 0.3x its 50-day average of 548.00K — lighter than usual.
- Price is -10.0% vs its 50-day average ($2.03) and +8.8% vs its 200-day average ($1.68).
- 52-week range $1.13–$2.89; today's close sits at 40% of that range, 36.7% below the 52-week high.
- That makes 3 straight losses.
LUNG latest news & SEC filings
Every SEC filing by or about LUNG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- French Glendon E. Iii sold 4,098 shares at $2.26 (≈$9.26K) on Sep 1, 2026
- French Glendon E. Iii sold 37,784 shares at $2.26 (≈$85.39K) on Sep 1, 2026
- French Glendon E. Iii sold 4,098 shares at $2.26 (≈$9.26K) on Sep 1, 2026
- French Glendon E. Iii sold 37,784 shares at $2.26 (≈$85.39K) on Sep 1, 2026
- French Glendon E. Iii sold 4,098 shares at $2.26 (≈$9.26K) on Sep 1, 2026
- French Glendon E. Iii sold 37,784 shares at $2.26 (≈$85.39K) on Sep 1, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lehman David Aaron sold 3,807 shares at $2.26 (≈$8.60K) on Sep 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rose Geoffrey Beran sold 2,213 shares at $2.26 (≈$5.00K) on Sep 1, 2026
- Rose Geoffrey Beran sold 1,530 shares at $2.26 (≈$3.46K) on Sep 1, 2026
- Rose Geoffrey Beran sold 1,746 shares at $2.26 (≈$3.95K) on Sep 1, 2026
- Rose Geoffrey Beran sold 2,390 shares at $2.26 (≈$5.40K) on Sep 1, 2026
- Rose Geoffrey Beran sold 2,213 shares at $2.26 (≈$5.00K) on Sep 1, 2026
- Rose Geoffrey Beran sold 1,530 shares at $2.26 (≈$3.46K) on Sep 1, 2026
- …plus 10 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $22.76M (prior year $23.86M) (-4.6% vs Jun 30, 2025)
- Net income: -$10.08M (prior year -$15.17M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.24 (prior year -$0.38) (loss narrowed vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade LUNG
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Mar 4, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.76% (largest 5.3%).
- Liquidity: about 262.86K shares (≈$467.89K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.78 vs a range of $1.13–$2.89 (37% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Geoffrey Beran Rose sold 2,213 shares on Sep 1, 2026.
- Latest filings: 10-Q Aug 4, 2026; 8-K Jul 29, 2026; 8-K Jun 4, 2026.
- Share count: 42.95M shares outstanding (Jul 31, 2026), +5.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
LUNG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.85 | 1.88 | 1.75 | 1.78 | 243.99K |
| Oct 15, 2026 | 1.77 | 1.88 | 1.77 | 1.85 | 268.10K |
| Oct 14, 2026 | 1.80 | 1.80 | 1.72 | 1.78 | 284.90K |
| Oct 13, 2026 | 1.79 | 1.87 | 1.74 | 1.76 | 498.60K |
| Oct 12, 2026 | 1.81 | 1.93 | 1.74 | 1.80 | 428.70K |
| Oct 9, 2026 | 1.81 | 1.90 | 1.81 | 1.84 | 204.40K |
| Oct 8, 2026 | 1.84 | 1.84 | 1.77 | 1.81 | 229.20K |
| Oct 7, 2026 | 1.75 | 1.90 | 1.75 | 1.84 | 379.70K |
| Oct 6, 2026 | 1.90 | 1.93 | 1.77 | 1.78 | 201.30K |
| Oct 5, 2026 | 1.85 | 1.92 | 1.79 | 1.88 | 283.70K |
| Oct 2, 2026 | 1.92 | 1.93 | 1.83 | 1.83 | 175.00K |
| Oct 1, 2026 | 1.89 | 1.93 | 1.87 | 1.91 | 166.80K |
| Sep 30, 2026 | 1.94 | 1.99 | 1.90 | 1.91 | 250.90K |
| Sep 29, 2026 | 1.96 | 2.00 | 1.95 | 1.98 | 253.90K |
| Sep 28, 2026 | 1.91 | 2.00 | 1.87 | 1.96 | 202.00K |
| Sep 25, 2026 | 1.98 | 1.99 | 1.90 | 1.91 | 304.40K |
| Sep 24, 2026 | 2.00 | 2.05 | 1.88 | 1.90 | 165.70K |
| Sep 23, 2026 | 2.06 | 2.06 | 2.00 | 2.00 | 128.00K |
| Sep 22, 2026 | 1.99 | 2.09 | 1.98 | 2.06 | 220.40K |
| Sep 21, 2026 | 2.07 | 2.08 | 1.93 | 1.99 | 367.50K |
About Pulmonx
Pulmonx (LUNG) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in REDWOOD CITY, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1127537.
LUNG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas William Burns | Director | Jun 9, 2026 |
| Richard Ferrari | Director | Jun 9, 2026 |
| Daniel P Florin | Director | Jun 9, 2026 |
| Glendon E. Iii French | President and CEO | Sep 3, 2026 |
| Dana G Jr. Mead | Director | Jun 9, 2026 |
| Georgia Melenikiotou | Director | Jun 9, 2026 |
| Tiffany Sullivan | Director | Jun 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Glendon E. Iii French | President and CEO | Sep 3, 2026 |
| David Aaron Lehman | General Counsel | Sep 3, 2026 |
| Srikanth Radhakrishnan | Chief Science & Techn. Officer | Sep 3, 2026 |
| Geoffrey Beran Rose | Chief Commercial Officer | Sep 3, 2026 |
| Derrick Sung | COO and CFO | Dec 3, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,213 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,530 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,746 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,390 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,213 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,530 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,746 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,390 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,213 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,530 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,746 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,390 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 2,213 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,530 | $2.26 |
| Sep 1, 2026 | Geoffrey Beran Rose | Sale | 1,746 | $2.26 |
LUNG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $90.50M | $-54.00M | -1.33 | $-32.38M |
| Dec 31, 2024 | $83.79M | $-56.39M | -1.44 | $-31.54M |
| Dec 31, 2023 | $68.67M | $-60.84M | -1.60 | $-37.61M |
| Dec 31, 2022 | $53.66M | $-58.92M | -1.59 | $-45.08M |
| Dec 31, 2021 | $48.42M | $-48.66M | -1.35 | $-41.39M |
Latest balance sheet: total assets $114.73M, total liabilities $75.54M, cash $55.84M (as of Jun 30, 2026).
LUNG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $1.25 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $1.20 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $1.44 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.96 |
| Oct 27, 2025 | 8-K Item 2.02 (results) | $1.56 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $3.15 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $4.83 |
| Feb 19, 2025 | 8-K Item 2.02 (results) | $6.64 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $6.79 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 21, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LUNG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.